|
|
 | | | |
- close
- close
- close
- close
Oncolytics Biotech Inc (ONC) |
QUOTE AND NEWS
PR Newswire
Apr 4
Comment
CALGARY, April 4, 2012 /PRNewswire/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC) (NASDAQ: ONCY), will present a corporate overview of the Company at the 11(th) Annual Needham Healthcare Conference on Wednesday, April
PR Newswire
Mar 2
Comment
CALGARY, March 2, 2012 /PRNewswire/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company at the Cowen and Company 32(nd) Annual Health Care Conference on Monday,
PR Newswire
Feb 21
Comment
CALGARY, Feb. 21, 2012 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that it has entered into an agreement whereby the NCIC Clinical Trials Group (CTG) at Queen's University in Kingston, Ontario, will
Canadian Business
Mar 17
Comment
CALGARY - Oncolytics Biotech Inc. (TSX:ONC), a Calgary-based drug developer, widened its losses in 2010 to nearly $20 million from $16.2 million
Canadian Business
Nov 10
Comment
CALGARY - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY), a small Calgary-based drug developer, widens its net loss in the third quarter to $4
Benzinga
Sep 28
Comment
Oncolytics Biotech Inc. (NASDAQ: ONCY) today announced that it has been granted U.S. Patent, # 7,803,385 entitled "Reoviruses Having Modified Sequences." The patent claims cover methods for making and using modified reoviruses, and pharmaceutical...
StreetInsider.com
May 12
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Oncolytics+Biotech%2C+Inc.+%28ONCY%29+Posts+Q1+Loss+of+%240.07%2C+Narrower+than+Views/5624857.html for the full story.
Globe Newswire
May 10
Comment
CALGARY, Alberta, May 10, 2010 (GLOBE NEWSWIRE) -- Emerging Stock Report, a leading provider of sector specific independent investment research, today initiated coverage on Oncolytics Biotech, Inc. (Nasdaq:ONCY). Emerging Stock Report is currently
Canadian Business
Oct 21
Comment
CALGARY - Oncolytics Biotech Inc. (TSX:ONC) said Tuesday it has made an investment worth $684,000 in British Canadian Biosciences Corp., a private
Globe Newswire
Oct 7
Comment
DALLAS, Oct. 7, 2009 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring Oncolytics Biotech Inc. (Nasdaq:ONCY). The report includes financial and investment analysis, analyst consensus, and pertinent industry information
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
